Schiapparelli Biosystems, Inc.

Schiapparelli Biosystems, Inc. — FDA 510(k) Submissions

Schiapparelli Biosystems, Inc. has submitted 24 FDA 510(k) premarket notifications since 1993, of which 24 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Enzyme Immunoassay, Diphenylhydantoin, Radioimmunoassay (two-site Solid Phase), Ferritin, Radioassay, Triiodothyronine Uptake, Catalytic Methods, Amylase, Enzyme Immunoassay, Non-radiolabeled, Total Thyroxine . Use the specialty filter in the sidebar to narrow results.